APA (7th ed.) Citation

Mehta-Shah, N., Jacobsen, E. D., Fehniger, T. A., Kahl, B. S., Bartlett, N. L., Cashen, A. F., . . . Horwitz, S. M. (2021). End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas. Blood, 138(Supplement 1), 3506. https://doi.org/10.1182/blood-2021-148768

Chicago Style (17th ed.) Citation

Mehta-Shah, Neha, et al. "End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas." Blood 138, no. Supplement 1 (2021): 3506. https://doi.org/10.1182/blood-2021-148768.

MLA (9th ed.) Citation

Mehta-Shah, Neha, et al. "End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas." Blood, vol. 138, no. Supplement 1, 2021, p. 3506, https://doi.org/10.1182/blood-2021-148768.